A Clinical Study Comparing the Bioavailability of HRS-2189 Tablets

NCT07639905 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Solid Tumor

Interventions

DRUG: HRS-2189 Tablet

Sponsor

Shandong Suncadia Medicine Co., Ltd.